Marpai, Inc. MRAI
Set alert
2.73 USD -0.09 -3.19%
As of Nov 3, 11:17 AM ET
2.73 Day range 2.90
0.215 52-week range 4.16
- YTD
- +332.65%
- 1 year
- +88.28%
- Open
- 2.90
- Prev close
- 2.82
- Mkt cap
- 73.25M
- Vol
- 973
- Avg vol
- 48.16K
- EPS
- -0.77
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.73
- High
- 2.90
- Forward P/E
- -2.29
- Beta
- 4.88
- Short ratio
- 0.11
- Inst. own
- 2.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.61
- 200-d avg
- 1.44
- 1y target
- 6.00
3M chart
Signals (8)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| SMA: Bearish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| RSI: Overbought | Sep 4, 2026 | 2 months ago |
| MACD: Buy Signal | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
Key statistics
- Market cap
- 9.60M
- Enterprise value
- 14.21M
- Trailing P/E
- 0.00
- Forward P/E
- -2.29
- PEG ratio
- 0.00
- Price / sales
- 0.28
- Price / book
- 0.00
- EPS (TTM)
- -2.92
- Beta
- 4.88
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -69.48%
- Revenue (TTM)
- 34.87M
- Revenue growth
- -23.60%
- Free cash flow
- -7.71M
- Total cash
- 851.00K
- Total debt
- 5.78M
- Return on equity
- 0.00%
- Shares outstanding
- 11.03M
- Short % of float
- 0.26%
- 50-day average
- 1.61
- 200-day average
- 1.44
Analyst view
Consensus: buy
Buy
Price target (mean) 6.00
Ratings (-1m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.51.
Financials — quick view
MRAI Revenue — quarterly 7.38M
MRAI Net income — quarterly -4.35M
MRAI EPS — quarterly -0.46
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | 0.00 | -0.30 | — | — |
| Aug 7, 2024 | Jun 1, 2024 | 0.00 | -1.23 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.46 | — | — |
| Mar 26, 2024 | Dec 1, 2023 | 0.00 | -0.65 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.98 | — | — |
| Aug 3, 2023 | Jun 1, 2023 | 0.00 | -1.10 | — | — |
About Marpai, Inc.
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- marpaihealth.com
News
- Opyn AI agents cut Marpai's provider call center costs by 40%
- Claritev Expands Collaboration With Marpai To Launch Pre, Post- Payment Integrity Services To Health Plans
- Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
- Marpai Reports Second Quarter 2026 Financial Results
- Marpai Announces $12 Million Private Placement led by Mitchell Companies
- Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
- Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026
- MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
- Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability
- Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide
Your note
Sign in to keep a note on MRAI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CALABRESE JENNIFER ROSARIO | Director | Stock Award(Grant) | Jan 16, 2024 | 50,000 |
| DENDY MICHAEL CHARLES | Director | Sale | May 9, 2024 | 0 |
| DICLAUDIO COLLEEN | Director | Stock Award(Grant) | May 22, 2024 | 60,000 |
| EITAN YARON I | Director | Stock Award(Grant) | Jun 2, 2024 | 673,454 |
| GONZALEZ EDMUNDO | Chief Executive Officer | Purchase | Sep 10, 2023 | 342,325 |
| JOHNSON STEVE ANDREW | Chief Financial Officer | Purchase | May 28, 2024 | 368,061 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sabby Management, LLC | 4.82% | 375,968 | 642.90K | Jun 29, 2023 |
| Vanguard Group Inc | 1.63% | 127,477 | 217.99K | Jun 29, 2023 |
| Altium Capital Management, LP | 1.51% | 117,848 | 201.52K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.13% | 10,207 | 17.45K | Jun 29, 2023 |
| Tower Research Capital LLC (TRC) | 0.07% | 5,700 | 9.75K | Jun 29, 2023 |
| UBS Group AG | 0.05% | 3,969 | 6.79K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.94% | 73,254 | 125.26K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.69% | 54,224 | 92.72K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.08% | 6,480 | 18.60K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.05% | 3,633 | 10.43K | May 30, 2023 |